Related Pharmacy Company in Massachusetts Recalling All Products
Ameridose LLC is a sister company to the New England Compouding Center (NECC), which produced contaminated injectable steroid drugs that have been linked to 29 deaths and 377 cases thus far.
Ameridose LLC and the FDA jointly announced Ameridose is voluntarily recalling all of its unexpired products that remain in circulation. The company is based in Westborough, Mass., and is a sister company to the New England Compounding Center (NECC), which produced contaminated injectable steroid drugs that have been linked to 29 deaths and 377 cases thus far, CDC announced Oct. 31 in its latest count of cases.
The Ameridose statement said the recall "represents an expansion of our cooperation with the U.S. Food and Drug Administration and the Massachusetts Board of Registration in Pharmacy. During the course of its on-going inspection of our facility, FDA has notified Ameridose that it will be seeking improvements in Ameridose's sterility testing process. Ameridose and FDA agree that the use of injectible products that are not sterile can represent a serious hazard to health and could lead to life-threatening injuries and/or death. Ameridose has not received any adverse reports related to the products subject to this recall and neither Ameridose nor the FDA has identified impurities in any Ameridose products. Nevertheless, out of an abundance of caution, we are undertaking this recall to assure customers that when Ameridose products are shipped, they are fully in conformance with all of the FDA's recommendations."
The statement indicated a complete list of products subject to the recall can be found at www.ameridose.com. "If you have any Ameridose products on hand, immediately examine your inventory and quarantine products subject to this recall," it says, asking that consumers complete a form outlining the current status of the products and fax it to Ameridose 508-656-6596 or email it to [email protected].